Frontage Expands In China With New Cancer Clinical Site In Changchun As CRO Space Heats Up
This article was originally published in PharmAsia News
Executive Summary
Global CRO Frontage announced its second clinical site in China and plans for another site in Nanjing to meet increasing early-phase clinical research needs in the country.